VYGR Additional VY1706 (Alzheimer's anti-tau Gene therapy) preclinical data bode well for program/company; reiterate BUY, $12PT @ Canaccord
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.